You searched for metabolic diseases - Page 47 of 64

Best in Biotech 12 Jun 2023

Six advancements in Alzheimer’s research over the past year

…not interfere with other cyclin-dependent kinases – enzymes that regulate the cell cycle. As P25 has been linked to multiple neurodegenerative diseases, this could be a therapeutic breakthrough for conditions…

June 12, 2023 - 12 minutesmins - By Roohi Mariam Peter

News and Trends 11 Aug 2022

First patient enrolled on Panbela’s trial for treatment of pancreatic cancer

…with programs ranging from pre-clinical to registration studies. SBP-101 is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition by exploiting an observed high affinity of the compound for…

August 11, 2022 - 3 minutesmins - By Liza Laws

young researchers entrepreneurs biotech europe 1

Best in Biotech 4 Apr 2017

Top Young Researchers Making Names for Themselves in Industry

…with an industrial yeast strain through metabolic engineering. Anastasia Krivoruchko After finishing her PhD at Carleton University, Canada, Anastasia Krivoruchko went on to do a postdoc at Chalmers University of…

April 4, 2017 - 4 minutesmins - By Denise Neves Gameiro

Best in Biotech 3 Oct 2023

Five impactful biotech companies to know in New York

…targeting diseases such as depression, Alzheimer’s disease agitation, migraine, narcolepsy, and fibromyalgia. In Just last year, the U.S. Food and Drug Administration (FDA) approved Axsome’s drug Auvelity (dextromethorphan HBr -bupropion…

October 3, 2023 - 8 minutesmins - By Willow Shah-Neville

News and Trends 7 Jul 2016

Engineered Microorganisms now able to directly produce Bioplastics for 3D-Printing

…This technological breakthrough involved developing an original metabolic pathway, and then engineering it into microbes. The result is a 100% PLA polymer of high molecular weight (i.e. a long chain)….

July 7, 2016 - 2 minutesmins - By Denise Neves Gameiro

In Depth 1 Aug 2022

The biggest US biotech investments in July 2022

The asthma specialist Areteia Therapeutics took the U.S.’ top private biotech investment crown in July 2022, with runners-up including liquid biopsy firm Delfi Diagnostics and the metabolic disease drug developer…

August 1, 2022 - 3 minutesmins - By Jonathan Smith

Sitryx immunometabolism cancer inflammation

News and Trends 8 Oct 2018

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

…growth through targeting metabolic pathways has the potential to deliver new approaches to treat a wide range of severe diseases, particularly in the areas of immuno-oncology and immuno-inflammation.” The…

October 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 30 Apr 2024

5 private biotech companies in China you should know about

…drugs, etc. These therapies are also being developed for several different disease areas, including cancer, autoimmune, metabolic, neurological, and infectious diseases. The company already has an approved PD-1 inhibitor, called…

April 30, 2024 - 6 minutesmins - By Willow Shah-Neville

News and Trends 8 Dec 2022

Laevoroc Oncology pushes for relapsed leukemia cure

…into the immunoregulatory functions of purine nucleoside phosphorylase (PNP) with Laevoroc’s PNP inhibitor, LR 09. The research shows that PNP is a novel metabolic immune checkpoint and LR 09 (Ulodesine),…

December 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Aug 2022

Epigenic Therapeutics raises $20M for gene editing technology

…metabolic, and rare disease models. About Epigenic Therapeutics Epigenic Therapeutics is dedicated to developing next generation gene editing therapy utilizing regulation of the epigenetic genome for a variety of diseases….

August 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Dec 2022

MetrioPharm reveals COVID-19 study data

MetrioPharm AG, a Swiss pharmaceutical company developing drugs for inflammatory diseases, has announced topline data from its CT05 phase IIa study of small molecule macrophage metabolic modulator MP1032 in COVID-19…

December 8, 2022 - 4 minutesmins - By Jim Cornall

In Depth 6 May 2025

The future of diabetes treatment: Is a cure possible?

…to multiple chronic diseases, including diabetes. Recent studies have explored interventions aimed at modulating the gut microbiota to improve glycemic control. For instance, fecal microbiota transplantation (FMT) has been investigated…

May 6, 2025 - 11 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Six advancements in Alzheimer’s research over the past year

First patient enrolled on Panbela’s trial for treatment of pancreatic cancer

Top Young Researchers Making Names for Themselves in Industry

Five impactful biotech companies to know in New York

Engineered Microorganisms now able to directly produce Bioplastics for 3D-Printing

The biggest US biotech investments in July 2022

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

5 private biotech companies in China you should know about

Laevoroc Oncology pushes for relapsed leukemia cure

Epigenic Therapeutics raises $20M for gene editing technology

MetrioPharm reveals COVID-19 study data

The future of diabetes treatment: Is a cure possible?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!